Next 10 |
2024-03-28 09:44:31 ET Summary Insulet Corporation, the maker of the Omnipod Insulin Management System, provides essential services to a patient group of 10 million diabetes patients and has experienced significant growth over the past decade. The company's wearable and discrete s...
2024-03-26 15:05:44 ET Tandem Diabetes Care (NASDAQ: TNDM) was a standout stock as Tuesday's trading session barreled to a close. The insulin pump maker's stock price was nearly 10% higher in mid-afternoon trading, thanks largely to a recommendation upgrade from an analyst. That per...
2024-03-26 09:29:13 ET More on Tandem Diabetes Care Tandem Diabetes Care, Inc. (TNDM) Q4 2023 Earnings Call Transcript Tandem Diabetes Care GAAP EPS of -$0.46 misses by $0.19, revenue of $196.8M misses by $6.05M Seeking Alpha’s Quant Rating on Tandem Diabetes ...
2024-03-25 18:00:02 ET Mathew Blackman from Stifel Nicolaus issued a price target of $37.00 for TNDM on 2024-03-25 17:14:00. The adjusted price target was set to $37.00. At the time of the announcement, TNDM was trading at $30.1. The overall price target consensus is at ...
DURHAM, N.C., March 18, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced that Jamie Macdonald will retire and transition his role as Chief Executive O...
2024-03-16 02:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-08 08:43:37 ET More on Insulet Insulet Corporation (PODD) Q4 2023 Earnings Call Transcript Insulet: An Interesting, Yet Expensive, Story Insulet Non-GAAP EPS of $1.40 beats by $0.74, revenue of $509.8M beats by $48.74M Insulet Q4 2023 Earnings Preview...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “notes”) in a private placement (the “offering”...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions and other factors, $250.0 million aggregate principal amount of its Convertible Senior Notes due 2029 (the “notes...
2024-02-23 23:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Tandem Diabetes Care Inc. Company Name:
TNDM Stock Symbol:
NASDAQ Market:
Tandem Diabetes Care Inc. Website:
2024-03-26 15:05:44 ET Tandem Diabetes Care (NASDAQ: TNDM) was a standout stock as Tuesday's trading session barreled to a close. The insulin pump maker's stock price was nearly 10% higher in mid-afternoon trading, thanks largely to a recommendation upgrade from an analyst. That per...
U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday. Shares of Tesla Inc (NASDAQ: TSLA) rose sharply during Tuesd...
2024-03-25 18:00:02 ET Mathew Blackman from Stifel Nicolaus issued a price target of $37.00 for TNDM on 2024-03-25 17:14:00. The adjusted price target was set to $37.00. At the time of the announcement, TNDM was trading at $30.1. The overall price target consensus is at ...